Risk factors for pulmonary hypertension in patients with thalassemia intermedia

European Journal of Haematology

Volumn 85, Issue 6, 2010, Pages 549-551

  Amoozgar, Hamid ^a   Farhani, Nahal ^a   Karimi, Mehran ^b  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN;

ADOLESCENT; ADULT; BLOOD CELL COUNT; CLINICAL FEATURE; ECHOCARDIOGRAPHY; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; LETTER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RISK FACTOR; SPLENECTOMY; THALASSEMIA; THALASSEMIA INTERMEDIA;

ADOLESCENT; ADULT; AGE FACTORS; BETA-THALASSEMIA; CHILD; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION, PULMONARY; MALE; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 78349273590     PISSN: 09024441     EISSN: 16000609     Source Type: Journal    
DOI: 10.1111/j.1600-0609.2010.01509.x     Document Type: Letter

References (12)

1. Haghshenas M, Zamani J. Thalassemia, 1st edn. Shiraz: Shiraz University of Medical Sciences Publishing Center, 1997.
2. Rashidighader F, Vahidshahi K. Evaluation of the pulmonary hypertension in thalassemia intermedia. Res Biol Sci 2008;3:794-7.
3. Aessops A, Stamatelos G, Skoumas V, Vassilopopulos G, Mantzourani M, Loucopoulos D. Pulmonary hypertension and right heart failure in patients with beta-thalassemia. Chest 1995;107:50-3.
4. Phrommintikul A, Sukonthasarn A, Kanjanavanit R, Nawarawong W. Splenectomy: a strong risk factor for pulmonary hypertension in patients with thalassaemia. Heart 2006;92:1467-72.
5. Borgna Pignatti C, Carnelli V, Caruso V. Thromboembolic events in beta thalassemia major: an Italian multicenter study. Acta Haematol 1998;99:76-9.
6. Singer ST, Kuypers FA, Styles L, Vichinshky EP, Foote D, Rosenfeld H. Pulmonary hypertension in thalassemia: association with platelet activation and hypercoagulable state. Am J Hematol 2006;81:670-5.
7. Walter PB, Fung EB, Killilea DW. Oxidative stress and inflammation in iron-overloaded patients with beta-thalassaemia or sickle cell disease. Br J Haematol 2006;135:254-63.
8. Aessops A, Farmakis D. Pulmonary hypertension in beta-thalassemia. Ann N Y Acad Sci 2005;1054:342-9.
9. Fung EB, Harmatz P, Milet M. Morbidity and mortality in chronically transfused subjects with thalassemia and sickle cell disease: a report from the multi-center study of iron overload. Am J Hematol 2006;8:110-26.
10. Otto C. Cardiomyopathies, hypertensive and pulmonary heart disease. In: Otto C, Pearlman AS, eds. Textbook of Clinical Echocardiography. Saunders, Philadelphia, PA: WB Saunders Co; 1995:243-278.
11. Morris CR, Kuypers FA, Kato GJ, Lavrisha L, Larkin S, Singer T, Vichinsky EP. Hemolysis-associated pulmonary hypertension in thalassemia. Ann N Y Acad Sci 2005;1054:481-5.
12. Taher AT, Musallam KM, Karimi M, El-Beshlawy A, Belhoul K, Daar S, Saned MS, El-Chafic AH, Fasulo MR, Cappellini MD. Overview on practices in thalassemia intermedia management aiming for lowering complication rates across a region of endemicity: the OPTIMAL CARE study. Blood 2010;115:1886-92.